Valinor secured $13 million in seed funding to scale its AI platform for patient selection in clinic...
The AMW Read
This is a standard seed-stage funding announcement for a new player in the Vertical AI healthcare sub-segment; it does not meet the $500M threshold for cross.§D.
NoveltySignificance
Healthcare & Bio · Player Map
Valinor secured $13 million in seed funding to scale its AI platform for patient selection in clinical trials. This investment accelerates the use of multimodal machine learning to predict patient responses, reducing development costs and improving trial success rates. The advancement promises faster delivery of life-saving treatments. #AIinHealthcare #ClinicalTrials #Biotech #MachineLearning #DrugDevelopment